August 21, 2002
National Pharmpak Has Recalled Premarin Tablets
- The Food and Drug Administration (FDA)
has released the
Premarin Tablets (conjugated estrogens tablets, USP), 1.25 mg, 100 tablet
bottles, Rx only. Recall # D-358-2.
Lot #9000481D, Exp. 01/05
(extended recall on 7/18/2002)
Lot #9980653, Exp. 01/03.
Recalling Firm: National Pharmpak Services, Inc., Zanesville, OH, by letter
on June 19, 2002.
Manufacturer: Ayerst Laboratories, Inc., Rouses Point, NY.Firm initiated
recall is ongoing.
Failure to meet USP dissolution specifications by manufacturer (Wyeth).
VOLUME OF PRODUCT IN COMMERCE
9,601 bottles (lot #9000481);8,800 bottles (lot #9980653)-extension.